246 related articles for article (PubMed ID: 21641954)
1. Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model.
Zawadka M; Polak M; Rabczenko D; Mosiej E; Augustynowicz E; Lutyńska A
Vaccine; 2011 Jul; 29(33):5488-94. PubMed ID: 21641954
[TBL] [Abstract][Full Text] [Related]
2. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D
Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
[TBL] [Abstract][Full Text] [Related]
4. Do Pertussis Vaccines Protect Against Bordetella parapertussis?
Liko J; Robison SG; Cieslak PR
Clin Infect Dis; 2017 Jun; 64(12):1795-1797. PubMed ID: 28369240
[TBL] [Abstract][Full Text] [Related]
5. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.
Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME
Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261
[TBL] [Abstract][Full Text] [Related]
6. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice.
Kammoun H; Feunou PF; Foligne B; Debrie AS; Raze D; Mielcarek N; Locht C
Vaccine; 2012 Aug; 30(40):5864-70. PubMed ID: 22814407
[TBL] [Abstract][Full Text] [Related]
7. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.
David S; van Furth R; Mooi FR
Vaccine; 2004 May; 22(15-16):1892-8. PubMed ID: 15121300
[TBL] [Abstract][Full Text] [Related]
8. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET
Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
Watanabe M; Nagai M
Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
[TBL] [Abstract][Full Text] [Related]
10. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.
Hegerle N; Paris AS; Brun D; Dore G; Njamkepo E; Guillot S; Guiso N
Clin Microbiol Infect; 2012 Sep; 18(9):E340-6. PubMed ID: 22717007
[TBL] [Abstract][Full Text] [Related]
11. O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.
Zhang X; Rodríguez ME; Harvill ET
PLoS One; 2009 Sep; 4(9):e6989. PubMed ID: 19750010
[TBL] [Abstract][Full Text] [Related]
12. Infection with Bordetella parapertussis but not Bordetella pertussis causes pertussis-like disease in older pigs.
Elahi S; Thompson DR; Strom S; O'Connor B; Babiuk LA; Gerdts V
J Infect Dis; 2008 Aug; 198(3):384-92. PubMed ID: 18540802
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model.
Willems RJ; Kamerbeek J; Geuijen CA; Top J; Gielen H; Gaastra W; Mooi FR
Vaccine; 1998 Feb; 16(4):410-6. PubMed ID: 9607064
[TBL] [Abstract][Full Text] [Related]
14. [Seroprevalence of antibodies against lipopolysaccharides of Bordetella parapertussis in patients with prolonged caught in Poland].
Rokosz N; Smietańska K; Rastawicki W; Jagielski M
Med Dosw Mikrobiol; 2012; 64(4):277-83. PubMed ID: 23484419
[TBL] [Abstract][Full Text] [Related]
15. Colonization of Bordetella pertussis clinical isolates that differ by pulsed field gel electrophoresis types in the lungs of naïve mice or mice immunized with the whole-cell pertussis vaccine used in Poland.
Polak M; Zawadka M; Mosiej E; Rabczenko D; Augustynowicz E; Guiso N; Lutyńska A
Arch Immunol Ther Exp (Warsz); 2015 Apr; 63(2):155-60. PubMed ID: 25297678
[TBL] [Abstract][Full Text] [Related]
16. Outer membrane vesicles as acellular vaccine against pertussis.
Roberts R; Moreno G; Bottero D; Gaillard ME; Fingermann M; Graieb A; Rumbo M; Hozbor D
Vaccine; 2008 Aug; 26(36):4639-46. PubMed ID: 18640169
[TBL] [Abstract][Full Text] [Related]
17. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
[TBL] [Abstract][Full Text] [Related]
18. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.
Bouchez V; Guiso N
Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280
[TBL] [Abstract][Full Text] [Related]
19. Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.
Long GH; Karanikas AT; Harvill ET; Read AF; Hudson PJ
Proc Biol Sci; 2010 Jul; 277(1690):2017-25. PubMed ID: 20200027
[TBL] [Abstract][Full Text] [Related]
20. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate.
Asensio CJ; Gaillard ME; Moreno G; Bottero D; Zurita E; Rumbo M; van der Ley P; van der Ark A; Hozbor D
Vaccine; 2011 Feb; 29(8):1649-56. PubMed ID: 21211579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]